Company Filing History:
2 out of 3,684 
1 out of 1,209 
Years Active: 2019-2022
Title: Antonio Sacco: Innovator in Cancer Treatment
Introduction
Antonio Sacco is a notable inventor based in Boston, MA (US), recognized for his contributions to the field of cancer treatment. He holds 2 patents that focus on innovative methods for addressing Waldenström's macroglobulinemia, a type of blood cancer. His work has the potential to significantly impact the lives of patients afflicted with this condition.
Latest Patents
Antonio Sacco's latest patents include methods for treating Waldenström's macroglobulinemia using an anti-CXCR4 antibody. The first patent outlines a method for treating a subject afflicted with this disease by administering a therapeutically effective amount of an antibody that specifically binds to the CXCR4 receptor on WM cells. The second patent reiterates this approach, emphasizing the therapeutic regimen for patients with C1013G/CXCR4-associated Waldenström's macroglobulinemia.
Career Highlights
Throughout his career, Antonio has worked with prominent organizations such as Bristol-Myers Squibb Company and Dana-Farber Cancer Institute Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Antonio has collaborated with esteemed colleagues, including Irene M. Ghobrial and Aldo M. Roccaro. These partnerships have further enhanced his research and development efforts in cancer treatment.
Conclusion
Antonio Sacco's innovative work in the treatment of Waldenström's macroglobulinemia showcases his dedication to improving patient outcomes through scientific advancements. His patents and collaborations reflect a commitment to addressing critical health challenges in oncology.